Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update
Cell Biochemistry and Function · 2024-10 · 42 (7)
DOI: 10.1002/cbf.4108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, online erschienen am 03.09.2024. Verfasst von Archana und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi, India. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Gastrointestinal Microbiome. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 210 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Short‐chain fatty acids (SCFAs) are essential molecules produced by gut bacteria that fuel intestinal cells and may also influence overall health. An imbalance of SCFAs can result in various acute and chronic diseases, including diabetes, obesity and colorectal cancer (CRC). This review delves into the multifaceted roles of SCFAs, including a brief discussion on their source and various gut‐residing bacteria. Primary techniques used for detection of SCFAs, including gas chromatography, high‐performance gas chromatography, nuclear magnetic resonance and capillary electrophoresis are also discussed through this article. This review study also compiles various synthesis pathways of SCFAs from diverse substrates such as sugar, acetone, ethanol and amino acids. The different pathways through which SCFAs enter cells for immune response regulation are also highlighted. A major emphasis is the discussion on diseases associated with SCFA dysregulation, such as anaemia, brain development, CRC, depression, obesity and diabetes. This includes exploring the relationship between SCFA levels across ethnicities and their connection with blood pressure and CRC. In conclusion, this review highlights the critical role of SCFAs in maintaining gut health and their implications in various diseases, emphasizing the need for further research on SCFA detection, synthesis and their potential as diagnostic biomarkers. Future studies of SCFAs will pave the way for the development of novel diagnostic tools and therapeutic strategies for optimizing gut health and preventing diseases associated with SCFA dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi, India.
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.
- National Institute of Immunology, New Delhi, India.
ORCID-Profile: Archana
Förderung
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Archana, Gupta, A. K., Noumani, A., Panday, D. K., Zaidi, F., Sahu, G. K., Joshi, G., Yadav, M., Borah, S. J., Susmitha, V., Mohan, A., Kumar, A., & Solanki, P. R. (2024). Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update. Cell Biochemistry and Function, 42(7). https://doi.org/10.1002/cbf.4108
Vancouver
Archana, Gupta AK, Noumani A, Panday DK, Zaidi F, Sahu GK, et al. Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update. Cell Biochemistry and Function. 2024;42(7). doi:10.1002/cbf.4108
BibTeX
@article{Archana2024,
author = {Archana and Gupta, Abhijeet Kumar and Noumani, Ashab and Panday, Dharmendra Kumar and Zaidi, Fareen and Sahu, Gaurav Kumar and Joshi, Gunjan and Yadav, Manisha and Borah, Shikha Jyoti and Susmitha, Vanne and Mohan, Anand and Kumar, Anil and Solanki, Pratima R},
title = {Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update},
journal = {Cell Biochemistry and Function},
year = {2024},
volume = {42},
number = {7},
doi = {10.1002/cbf.4108}
}
EUVIMED